AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.


Company Details

Registered Office: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Postal Address: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Telephone: +64 9 488 0232
Facsimile: n/a
Website: www.aftpharm.com
First Listed: 22/12/2015
Balance Date: 31 March
AGM: 04/08/2023

Directors and Executives

Hartley Atkinson
Executive Director
Marree Atkinson
Executive Director
Anita Baldauf
Independent Director
David Flacks
Chairman
Andrew Lane
Director
Malcolm Tubby
CFO / Company Secretary
Ted Witek
Independent Non-Executive Director

Announcements

Title Date Type
Disclosure of Directors and Senior Managers Relevant Intere Fri, Jun 27 2025 08:42 am SHINTR
Notice of Annual Meeting of Shareholders 2025 Fri, Jun 27 2025 08:39 am MEETING
Annual Meeting and Closing Date for Director Nominations Fri, May 30 2025 08:59 am MEETING
AFT and Hikma extend US Maxigesic Cooperation Mon, May 26 2025 08:38 am GENERAL
Corrected Distribution Notice Thu, May 22 2025 12:18 pm CORPACT
AFT sees strong FY 26 as revenue reaches new record Thu, May 22 2025 08:30 am FLLYR
AFT to announce full year results on Thursday May 22 2025 Thu, May 01 2025 08:48 am GENERAL
March investor update Mon, Mar 31 2025 10:03 am GENERAL
ASX Small Cap presentation 250326 Wed, Mar 26 2025 08:50 am GENERAL
NEW YEAR LETTER TO INVESTORS Mon, Jan 13 2025 08:30 am GENERAL

Major Holdings Announcements

Date Name No. Held % Current
16/09/20 Forsyth Barr Group Limited and Fors 1,617,818 71.25 1.55
15/06/20 Hartley Campbell Atkinson and Colin 72,031,609 72.60 69.82
15/06/20 The CRG Persons - 15.99 -
25/05/17 AFT Pharmaceuticals Limited - 72.34 -

Director’s Interests Announcements

Date Name No. Held % Details Other
18/09/23 Jon Lamb 271,314 - - -
14/04/21 Malcolm Tubby 143,892 - - -
10/08/20 Hartley Atkinson 72,899,435 - - -
03/07/20 David Flacks 178,764 - - -
22/08/18 James Burns 125,417 - - -
19/06/17 John Douglas Wilson 56,689 - - -

Analysts’ Forecasts

profit2021 profit2022 eps2021 dps2021 sales2021 ebit2021 ebitda2021
mean 13.7 13.1 2.0 191.3 22.0 24.6
high 13.7 13.1 2.0 191.3 22.0 24.6
low 13.7 13.1 2.0 191.3 22.0 24.6
sample 1 0 1 1 1 1 1

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 04/07/2023


Markets News

Monthly CPI tech takes Stats NZ into the future
Economy

Monthly CPI tech takes Stats NZ into the future

Budget funding for new inflation-reporting tech is a giant leap forward, agency says.

Markets Market Close

Fonterra leads NZ sharemarket rise

The NZX 50 grew by 0.15% to 12,480.05 as Fonterra performed well.

Tom Raynel 26 Jun 2025
Fonterra leads NZ sharemarket rise
Markets Market close

NZ sharemarket flat despite export growth

The NZ sharemarket dipped as Fletcher Building shares fell further.

Tom Raynel 25 Jun 2025
NZ sharemarket flat despite export growth
Markets

FMA to focus on private market offers

The FMA is worried about unsophisticated investors taking the bait.

Pattrick Smellie 25 Jun 2025
FMA to focus on private market offers
Markets

Xero splashes $4.1b for 'step-change' US acquisition

Buying Melio gives Xero a leg-up in the crucial US SME market.

Pattrick Smellie 25 Jun 2025
Xero splashes $4.1b for 'step-change' US acquisition